Novo Nordisk | NVO - Market Capitalization

Stock Price
37.46
Daily Change
-0.95 -2.47%
Monthly
-22.68%
Yearly
-52.54%
Q1 Forecast
35.99

Novo Nordisk reported DKK126.2B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
ANI Pharmaceuticals USD 1.77B 269M Dec/2025
Aurora Cannabis CAD 261.6M 65.61M Mar/2026
Bausch Health Companies USD 2.58B 194.9M Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Canopy Growth CAD 781.35M 426.11M Sep/2025
Corcept Therapeutics USD 3.66B 5.1B Dec/2025
Drreddys Laboratories INR 11.69B 50M Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 265.66B 9.48B Sep/2025
Novo Nordisk A/S DKK 1.45T 86.62B Dec/2025
Pacira USD 1.06B 94M Dec/2025
Perrigo USD 1.4B 520M Mar/2026
Phibro Animal Health USD 2B 490M Mar/2026
Prestige Brands USD 2.97B 105M Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Supernus Pharmaceuticals USD 2.85B 151M Dec/2025
Zoetis USD 55.45B 9.4B Dec/2025